Heart & Lung: The Journal of Acute and Critical Care
Volume 36, Issue 1 , Pages 64-71, January 2007

Coccidioides immitis fungemia: Clinical features and survival in 33 adult patients

Presented in-part in Critical Care Medicine 2001;29:12 (supplement) A1061 and Critical Care Medicine 1999;27:A122.2

  • Silke Rempe, MD

      Affiliations

    • Pulmonary/Critical Care Carl T. Hayden VA Good Samaritan Medical Center, Phoenix, Arizona
  • ,
  • Mankanwal S. Sachdev, MD

      Affiliations

    • Hepatology Mayo Clinic-Scottsdale, Scottsdale, Arizona
  • ,
  • Rajesh Bhakta, MD

      Affiliations

    • Premier Physicians, Goodyear, Arizona
  • ,
  • Mauricio Pineda-Roman, MD

      Affiliations

    • Hematology/Oncology Medical University of South Carolina, Charleston, South Carolina
  • ,
  • Austin Vaz, MD

      Affiliations

    • Rheumatology Section, University of Arizona College of Medicine, University Medical Center, Tucson, Arizona
  • ,
  • Richard W. Carlson, MD, PhD, FCCM

      Affiliations

    • Department of Medicine, Maricopa Medical Center, Phoenix, Arizona
    • Mayo Medical School and University of Arizona, Arizona
    • Corresponding Author InformationReprint requests: Richard W. Carlson, MD, PhD, FCCM, Chair, Department of Medicine, Maricopa Medical Center, 2601 E. Roosevelt, Rm 6-B-09, Phoenix, AZ 85008.

Coccidioides immitis is a fungus endemic to the southwestern United States. Susceptible hosts, including blacks, Hispanics, Filipinos, Native Americans, and those with compromised immunity, may develop disseminated disease, including fungemia. We retrospectively reviewed the records of all patients (n = 33) with Coccidioides immitis fungemia (CIF) at a 550-bed public hospital in Phoenix, Arizona, from 1990 to 2002. This is the largest reported series of CIF. The purpose of the study was to review the incidence, signs, symptoms, and outcomes of CIF. Twenty-nine patients had human immunodeficiency virus infection. CIF was associated with sepsis, end-stage alcoholic liver disease, and diabetes in four patients. Survival was poor; 24 of the 33 patients died within 28 days. CIF manifested as a systemic inflammatory response syndrome with progressive cardiorespiratory failure. Despite fluid loading, infusion of vasoactive agents, and mechanical ventilation with positive end-expiratory pressure, patients typically experienced a rapidly progressive course and death. CIF portends an ominous prognosis and typically occurs in the setting of advanced human immunodeficiency virus or medical or surgical crises.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 12.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 All authors were at the Maricopa Medical Center at the time of their contribution to this article.Drs. Sachdev and Rempe contributed equally to the article.The authors state that this material has not received commercial support and is not under submission at another publication. We do not have any personal financial interests in the material.

PII: S0147-9563(06)00233-0

doi:10.1016/j.hrtlng.2006.10.001

Heart & Lung: The Journal of Acute and Critical Care
Volume 36, Issue 1 , Pages 64-71, January 2007